Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study.

Oakes TMM, Skljarevski V, Zhang Q, Kielbasa W, Hodsdon ME, Detke HC, Camporeale A, Saper JR.

Cephalalgia. 2018 May;38(6):1015-1025. doi: 10.1177/0333102417747230. Epub 2018 Jan 8.

PMID:
29310444
2.

Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial.

Wilkinson D, Ade KK, Rogers LL, Attix DK, Kuchibhatla M, Slade MD, Smith LL, Poynter KP, Laskowitz DT, Freeman MC, Hoffer ME, Saper JR, Scott DL, Sakel M, Calhoun AH, Black RD.

Headache. 2017 Jul;57(7):1065-1087. doi: 10.1111/head.13120. Epub 2017 Jun 27.

PMID:
28656612
3.

Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study.

Silberstein SD, Mechtler LL, Kudrow DB, Calhoun AH, McClure C, Saper JR, Liebler EJ, Rubenstein Engel E, Tepper SJ; ACT1 Study Group.

Headache. 2016 Sep;56(8):1317-32. doi: 10.1111/head.12896.

4.

Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study.

Silberstein SD, Calhoun AH, Lipton RB, Grosberg BM, Cady RK, Dorlas S, Simmons KA, Mullin C, Liebler EJ, Goadsby PJ, Saper JR; EVENT Study Group.

Neurology. 2016 Aug 2;87(5):529-38. doi: 10.1212/WNL.0000000000002918. Epub 2016 Jul 13.

5.

Are Chronic and Episodic Migraine Distinct Neurophysiological Entities? More Research is Needed.

Saper JR.

Pain Med. 2015 Jul;16(7):1246. doi: 10.1111/pme.12805. Epub 2015 Jun 5. No abstract available.

PMID:
26052746
6.

Medication overuse headache: history, features, prevention and management strategies.

Saper JR, Da Silva AN.

CNS Drugs. 2013 Nov;27(11):867-77. doi: 10.1007/s40263-013-0081-y. Review.

PMID:
23925669
7.

Oral methylergonovine maleate for refractory migraine and cluster headache prevention.

Saper JR, Evans RW.

Headache. 2013 Feb;53(2):378-81. doi: 10.1111/head.12033. Review. No abstract available.

PMID:
23432443
8.

Migraine headache is present in the aura phase: a prospective study.

Hansen JM, Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Goadsby PJ, Charles A.

Neurology. 2012 Nov 13;79(20):2044-9. doi: 10.1212/WNL.0b013e3182749eed. Epub 2012 Oct 31.

9.

Randomized, controlled trial of telcagepant over four migraine attacks.

Ho AP, Dahlöf CG, Silberstein SD, Saper JR, Ashina M, Kost JT, Froman S, Leibensperger H, Lines CR, Ho TW.

Cephalalgia. 2010 Dec;30(12):1443-57. doi: 10.1177/0333102410370878. Epub 2010 Jun 8.

PMID:
20974601
10.

Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: results from the International Migraine Pain Assessment Clinical Trial (IMPACT).

Lipton RB, Grosberg B, Singer RP, Pearlman SH, Sorrentino JV, Quiring JN, Saper JR.

Cephalalgia. 2010 Nov;30(11):1336-45. doi: 10.1177/0333102410367523. Epub 2010 Apr 7.

PMID:
20959428
11.

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.

Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ; ONSTIM Investigators.

Cephalalgia. 2011 Feb;31(3):271-85. doi: 10.1177/0333102410381142. Epub 2010 Sep 22.

12.

A practice guide for continuous opioid therapy for refractory daily headache: patient selection, physician requirements, and treatment monitoring.

Saper JR, Lake AE 3rd, Bain PA, Stillman MJ, Rothrock JF, Mathew NT, Hamel RL, Moriarty M, Tietjen GE.

Headache. 2010 Jul;50(7):1175-93. doi: 10.1111/j.1526-4610.2010.01733.x. Review.

13.

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.

Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, Fischell RE, Ruppel PL, Goadsby PJ.

Lancet Neurol. 2010 Apr;9(4):373-80. doi: 10.1016/S1474-4422(10)70054-5. Epub 2010 Mar 4.

PMID:
20206581
14.

Comprehensive inpatient treatment of refractory chronic daily headache.

Lake AE 3rd, Saper JR, Hamel RL.

Headache. 2009 Apr;49(4):555-62. doi: 10.1111/j.1526-4610.2009.01364.x. Epub 2009 Feb 25.

PMID:
19245391
15.

Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines.

Saper JR, Lake AE 3rd.

Headache. 2008 Jun;48(6):838-49. doi: 10.1111/j.1526-4610.2008.01153.x. Review.

PMID:
18549361
16.

Pearls from an inpatient headache unit.

Saper JR.

Headache. 2008 Jun;48(6):820-7. doi: 10.1111/j.1526-4610.2008.01141.x. Review.

PMID:
18549359
17.

Fifty years of headache care evolution: from a few interested doctors to certified specialists and comprehensive systems.

Saper JR.

Headache. 2008 May;48(5):701-3. doi: 10.1111/j.1526-4610.2008.01100.x.

PMID:
18471115
18.

Chronic daily headache: transformational migraine, chronic migraine, and related disorders.

Saper JR.

Curr Neurol Neurosci Rep. 2008 Mar;8(2):100-7. Review.

PMID:
18460277
19.

A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.

Saper JR, Mathew NT, Loder EW, DeGryse R, VanDenburgh AM; BoNTA-009 Study Group.

Pain Med. 2007 Sep;8(6):478-85.

PMID:
17716321
20.

Teaching case: Sinus headache.

Cooper W, Saper JR.

Headache. 2007 Mar;47(3):463-6. No abstract available.

PMID:
17371375
21.

DHE in the pharmacotherapy of migraine: potential for a larger role.

Saper JR, Silberstein S, Dodick D, Rapoport A.

Headache. 2006 Nov;46 Suppl 4:S212-20. Review.

PMID:
17078853
22.

Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine.

Saper JR, Silberstein S.

Headache. 2006 Nov;46 Suppl 4:S171-81. Review.

PMID:
17078849
23.

Psychiatric comorbidity with chronic headache: evidence-based clinical implications--introduction to the supplement.

Lake AE 3rd, Lipchik GL, Penzien DB, Rains JC, Saper JR, Lipton RB.

Headache. 2006 Oct;46 Suppl 3:S73-5. Review. No abstract available. Erratum in: Headache. 2007 Feb;47(2):347.

PMID:
17034401
24.
25.

Medication overuse headache: type I and type II.

Saper JR, Lake AE 3rd.

Cephalalgia. 2006 Oct;26(10):1262. No abstract available.

PMID:
16961800
27.

Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.

Goldstein J, Silberstein SD, Saper JR, Elkind AH, Smith TR, Gallagher RM, Battikha JP, Hoffman H, Baggish J.

Headache. 2005 Sep;45(8):973-82.

PMID:
16109110
28.

Medication overuse headache (MOH) is a biobehavioural disorder.

Saper JR, Hamel RL, Lake AE 3rd.

Cephalalgia. 2005 Jul;25(7):545-6. No abstract available.

PMID:
15955043
29.
30.

Editorial to the guidelines for trials of behavioral treatments for recurrent headache.

Saper JR.

Headache. 2005 May;45 Suppl 2:S90-1. No abstract available.

PMID:
15921505
31.

Management of chronic daily headache: challenges in clinical practice.

Saper JR, Dodick D, Gladstone JP.

Headache. 2005 Apr;45 Suppl 1:S74-85. Review.

PMID:
15833093
32.

Abrupt onset and termination of cutaneous allodynia (central sensitization) during attacks of SUNCT.

Rozen TD, Haynes GV, Saper JR, Sheftell FD.

Headache. 2005 Feb;45(2):153-5.

PMID:
15705121
33.

Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache.

Swidan SZ, Lake AE 3rd, Saper JR.

Curr Pain Headache Rep. 2005 Feb;9(1):65-70.

PMID:
15625028
34.

Comprehensive/tertiary care for headache: a 6-month outcome study.

Saper JR, Lake AE 3rd, Madden SF, Kreeger C.

Headache. 1999 Apr;39(4):249-63.

PMID:
15613222
35.

Opioid tolerance or rather opioid-induced pain sensitivity.

Taylor FR, Saper JR.

Headache. 2004 Sep;44(8):839-40. No abstract available.

PMID:
15330840
36.

Daily scheduled opioids for intractable head pain: long-term observations of a treatment program.

Saper JR, Lake AE 3rd, Hamel RL, Lutz TE, Branca B, Sims DB, Kroll MM.

Neurology. 2004 May 25;62(10):1687-94.

PMID:
15159463
37.

Topiramate for migraine prevention: a randomized controlled trial.

Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D; MIGR-002 Study Group.

JAMA. 2004 Feb 25;291(8):965-73.

PMID:
14982912
38.

Botulinum toxin and chronic facial pain.

Saper JR.

J Pain. 2002 Feb;3(1):2. No abstract available.

PMID:
14622847
39.

Why headache treatment fails.

Lipton RB, Silberstein SD, Saper JR, Bigal ME, Goadsby PJ.

Neurology. 2003 Apr 8;60(7):1064-70. Review.

PMID:
12682307
40.

Borderline personality disorder and the chronic headache patient: review and management recommendations.

Saper JR, Lake AE 3rd.

Headache. 2002 Jul-Aug;42(7):663-74. Review.

PMID:
12482221
41.

Chronic headache: New advances in treatment strategies.

Lake AE 3rd, Saper JR.

Neurology. 2002 Sep 10;59(5 Suppl 2):S8-13. Review.

PMID:
12221150
42.

Chronic daily headache: a clinician's perspective.

Saper JR.

Headache. 2002 Jun;42(6):538-42. Review. No abstract available.

PMID:
12167147
43.

Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.

Saper JR, Lake AE 3rd, Cantrell DT, Winner PK, White JR.

Headache. 2002 Jun;42(6):470-82.

PMID:
12167135
44.

Intranasal civamide for the treatment of episodic cluster headaches.

Saper JR, Klapper J, Mathew NT, Rapoport A, Phillips SB, Bernstein JE.

Arch Neurol. 2002 Jun;59(6):990-4.

PMID:
12056936
45.

What matters is not the differences between triptans, but the differences between patients.

Saper JR.

Arch Neurol. 2001 Sep;58(9):1481-2. Review. No abstract available.

PMID:
11559323
46.

Nefazodone for chronic daily headache prophylaxis: an open-label study.

Saper JR, Lake AE, Tepper SJ.

Headache. 2001 May;41(5):465-74.

PMID:
11380644
47.

Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine.

Freitag FG, Cady R, DiSerio F, Elkind A, Gallagher RM, Goldstein J, Klapper JA, Rapoport AM, Sadowsky C, Saper JR, Smith TR.

Headache. 2001 Apr;41(4):391-8.

PMID:
11318886
49.

Geriatric headache. How to make the diagnosis and manage the pain.

Biondi DM, Saper JR.

Geriatrics. 2000 Dec;55(12):40, 43-5, 48-50.

PMID:
11131853
50.

Posttraumatic headache: a neurobehavioral disorder.

Saper JR.

Arch Neurol. 2000 Dec;57(12):1776-8; discussion 1780-1. No abstract available.

PMID:
11115246

Supplemental Content

Loading ...
Support Center